All In Biotech

Drug Trial Radar · NCT03216447

A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

A Prospective, Multi-center, Open-labeled, Randomized Clinical Trial of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant Recipients to Compare QD Early Conversion and BID Tacrolimus Formulation.

Last checked: Nov 20, 2026Latest source record: Jun 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

150

Planned (sponsor's estimate)

Start

Nov 23, 2017

Primary completion

Aug 31, 2023

Study completion Sep 30, 2025

Sponsor

Lead sponsor
Chang Gung Memorial HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Astellas Pharma Taiwan, Inc.
First posted
Jul 13, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study of patient adherence and convenience to immunosuppressive agents in newly liver transplant recipients - a prospective, multi-center, open-labeled, randomized clinical trial for comparison between once-daily early conversion and twice-daily tacrolimus formulation.

Conditions

  • Liver Transplantation

Interventions

  • AdvagrafDrug

    Tacrolimus prolonged-release hard capsules (QD)

  • PrografDrug

    Tacolimus capsules (q12h)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adherence of administration of Advagraf in newly Taiwanese (Chinese) liver transplant patients.Time frame: Visit 1 (Day 14) to Visit 6 (Day 364) - 50 weeks observation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chang Gung Memorial Hospital

    Taoyuan, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.